These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38951295)

  • 1. Which drug would be more effective in treating patients with leptomeningeal metastases from breast cancer: intrathecal thiotepa or methotrexate?
    Altundag K
    Med Oncol; 2024 Jun; 41(8):189. PubMed ID: 38951295
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
    Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
    Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intrathecal chemotherapy for leptomeningeal metastases in patients with breast cancer].
    Moskvina EA; Belov DM; Naskhletashvili DR; Mekheda LV; Bekyashev AK; Aleshin VA; Gasparyan TG; Mitrofanov AA; Sevyan NV; Prozorenko EV; Tkhazeplov AA; Roshchina KE
    Zh Vopr Neirokhir Im N N Burdenko; 2024; 88(3):31-37. PubMed ID: 38881013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer.
    Ferrario C; Davidson A; Bouganim N; Aloyz R; Panasci LC
    Ann Oncol; 2009 Apr; 20(4):792-5. PubMed ID: 19223574
    [No Abstract]   [Full Text] [Related]  

  • 5. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
    Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
    Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review on the Efficacy and Safety of Intrathecal Administration of Novel Medications for Leptomeningeal Metastases in Solid Cancers.
    Jafari F; Nodeh MM; Hosseinjani H; Baharara H; Azad S; Arasteh O; Johnston TP; Sahebkar A
    Curr Med Chem; 2024; 31(19):2732-2750. PubMed ID: 37157199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
    Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
    Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intrathecal methotrexate in breast cancer meningeal carcinomatosis - Experience with a new administration schedule].
    Cochereau D; Da Costa S; Le Maignan C; Gauthier H; Cochereau J; Espié M; Giacchetti S; Teixeira L
    Bull Cancer; 2016 May; 103(5):444-54. PubMed ID: 26987841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.
    Mego M; Sycova-Mila Z; Obertova J; Rajec J; Liskova S; Palacka P; Porsok S; Mardiak J
    Breast; 2011 Oct; 20(5):478-80. PubMed ID: 21700455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa.
    Comte A; Jdid W; Guilhaume MN; Kriegel I; Piperno-Neumann S; Dieras V; Dorval T; Pierga JY; Cottu PH; Mignot L; Bidard FC
    J Neurooncol; 2013 Dec; 115(3):445-52. PubMed ID: 24043602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid clinical and radiographic improvement after intrathecal trastuzumab and methotrexate in a patient with HER-2 positive leptomeningeal metastases.
    Martens J; Venuturumilli P; Corbets L; Bestul D
    Acta Oncol; 2013 Jan; 52(1):175-8. PubMed ID: 22655969
    [No Abstract]   [Full Text] [Related]  

  • 12. [Three Cases of Intrathecal Chemotherapy with Ventricular Catheter for the Treatment of Leptomeningeal Metastasis from Breast Cancer].
    Miyoshi K; Takahashi H; Uno M; Akai M; Moriyama E; Nakagawa T; Nomura T
    Gan To Kagaku Ryoho; 2018 Dec; 45(12):1767-1769. PubMed ID: 30587738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant intravenous eribulin.
    Salgia S; Fleming GF; Lukas RV
    J Clin Neurosci; 2014 Jul; 21(7):1250-1. PubMed ID: 24412296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous thiotepa for treatment of breast cancer-related leptomeningeal carcinomatosis: case series.
    Chahal J; Stopeck A; Clarke K; Livingston RB; Chalasani P
    Neurol Sci; 2015 Sep; 36(9):1691-3. PubMed ID: 25990104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.
    Figura NB; Rizk VT; Mohammadi H; Evernden B; Mokhtari S; Yu HM; Robinson TJ; Etame AB; Tran ND; Liu J; Washington I; Diaz R; Czerniecki BJ; Soliman H; Han HS; Sahebjam S; Forsyth PA; Ahmed KA
    Breast Cancer Res Treat; 2019 Jun; 175(3):781-788. PubMed ID: 30859348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronomic Capecitabine Effectively Blocks Leptomeningeal Carcinomatosis From Breast Cancer: A Case Report and Literature Review.
    Maur M; Omarini C; Piacentini F; Fontana A; Pettorelli E; Cascinu S
    Am J Case Rep; 2017 Feb; 18():208-211. PubMed ID: 28242865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
    Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V
    Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
    Fizazi K; Asselain B; Vincent-Salomon A; Jouve M; Dieras V; Palangie T; Beuzeboc P; Dorval T; Pouillart P
    Cancer; 1996 Apr; 77(7):1315-23. PubMed ID: 8608509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal Trastuzumab as a Potential Cause of Drug-Induced Aseptic Meningitis.
    Pappa E; Conforti R; Hoang-Xuan K; Alentorn A
    Can J Neurol Sci; 2019 May; 46(3):358-359. PubMed ID: 30905325
    [No Abstract]   [Full Text] [Related]  

  • 20. Sanctuary site leptomeningeal metastases in HER-2 positive breast cancer: A review in the era of trastuzumab.
    Kordbacheh T; Law WY; Smith IE
    Breast; 2016 Apr; 26():54-8. PubMed ID: 27017242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.